Gary Shelton

Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer

Daniel P. Petrylak, Robert B. MacArthur, John F. O’Connor et al. · Journal of Clinical Oncology · 1999 · 312 citations

Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer.

Daniel P. Petrylak, Robert B. MacArthur, Jacqueline M. O’Connor et al. · PubMed · 1999 · 93 citations

DEXAMETHASONE DOES NOT SIGNIFICANTLY CONTRIBUTE TO THE RESPONSE RATE OF DOCETAXEL AND ESTRAMUSTINE IN ANDROGEN INDEPENDENT PROSTATE CANCER

Aaron Weitzman, Gary Shelton, Nancy Zuech et al. · The Journal of Urology · 2000 · 61 citations

Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma

Stephen A. Boorjian, Matthew I. Milowsky, Jodi Kaplan et al. · Journal of Immunotherapy · 2007 · 49 citations

Phase I trial of interferon α2b and liposome‐encapsulated all‐<i>trans</i> retinoic acid in the treatment of patients with advanced renal cell carcinoma

Jonathan S. Goldberg, Manuel Vargas, Alyssa S. Rosmarin et al. · Cancer · 2002 · 22 citations · Full text